Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-05-15
2007-05-15
Brusca, John S. (Department: 1631)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S006120, C435S235100, C536S024300, C702S020000
Reexamination Certificate
active
10604944
ABSTRACT:
The present invention relates to a group of novel viral RNA regulatory genes, here identified as “viral genomic address messenger genes” or “VGAM genes”, and as “genomic record” or “GR” genes. VGAM genes selectively inhibit translation of known host target genes, and are believed to represent a novel pervasive viral attack mechanism. GR genes encode an operon-like cluster of VGAM genes. VGAM and viral GR genes may therefore be useful in diagnosing, preventing and treating viral disease. Several nucleic acid molecules are provided respectively encoding several VGAM genes, as are vectors and probes, both comprising the nucleic acid molecules, and methods and systems for detecting VGAM genes, and for counteracting their activity.
REFERENCES:
patent: 6573099 (2003-06-01), Graham
patent: 6720138 (2004-04-01), Sharma
patent: 6753139 (2004-06-01), Baulcombe
patent: 6989442 (2006-01-01), Vargeese
patent: 2002/0086356 (2002-07-01), Tuschl
patent: 2003/0108923 (2003-06-01), Tuschl
patent: 2003/0175950 (2003-09-01), McSwiggen
patent: 2003/0228691 (2003-12-01), Lewis
patent: 2004/0086884 (2004-05-01), Beach
patent: 2004/0106566 (2004-06-01), Lin
patent: 2004/0268441 (2004-12-01), Vance
patent: 2005/0059011 (2005-03-01), Sin
patent: WO 01/68836 (2001-09-01), None
patent: WO 01/75164 (2001-10-01), None
patent: WO 02/44321 (2002-06-01), None
patent: WO 02/094165 (2002-11-01), None
patent: WO 03/029459 (2003-04-01), None
patent: WO 03/070884 (2003-08-01), None
patent: WO 03/070903 (2003-08-01), None
patent: WO 03/070918 (2003-08-01), None
patent: WO 03/074654 (2003-09-01), None
patent: WO 2004/009779 (2004-01-01), None
Brander et al. “Lack of Strong Immune Selection Pressure by the Immunodominant HLA-A*0201-restricted Cytotoxic T Lymphocyte Response in Chronic Human Immunodeficiency Virus-1 Infection” J. Clin. Invest. (Jun. 1998) vol. 101, No. 11, pp. 2559-2566.
Elbashir, S., et al., “Duplexes of 21-Nucleotide RNAs Mediate RNA Interference in Cultured Mammalian Cells,” Nature, vol. 411, pp. 494-498 (2001).
Carrington, J., et al., “Role of MicroRNAs in Plant and Animal Development,” Science, vol. 301, pp. 336-338 (2003).
Coburn, Glen, et al., “Potent and Specific Inhibition of Human Immunodeficiency Virus Type 1 Replication by RNA Intereference,” Journal of Virology, vol. 76, No. 18, pp. 9225-9231 (2002).
Hutvágner, G., et al., “A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of thelet-7Small Temporal RNA,” Science, vol. 293, pp. 834-838 (2001).
Mallory, A., et al., “A Viral Suppressor of RNA Silencing Differentially Regulates the Accumulation of Short Interfering RNAs and Micro-RNAs in Tobacco,” PINAS, vol. 99, No. 23, pp. 15228-15233 (2002).
Li, H., et al., “Induction and Suppression of RNA Silencing by an Animal Virus,” Science, vol. 296, pp. 1319-1321 (2002).
Llave, C., et al., “Virus-Encoded Suppressor of Posttranscriptional Gene Silencing Targets a Maintenance Step in the Silencing Pathway,” PNAS, vol. 97, No. 24, pp. 13401-13406 (2000).
Novina, C., et al., “siRNA-Directed Inhibition of HIV-1 Infection,” Nature Medicine, vol. 8, No. 7, pp. 681-686 (2002).
Provost, P., et al., “Ribonuclease Activity and RNA Binding of Recombinant Human Dicer,” EMBO Journal, vol. 21, No. 21, pp. 5864-5874 (2002).
Pomerantz, R., “RNA Interference Meets HIV-1: Will Silence be Golden?” Nature Medicine, vol. 8, No. 7, pp. 659-660 (2002).
Ryo, A., et al., “Serial Analysis of Gene Expression in HIV-1 Infected T Cell Lines,” FEBS Letters 462, pp. 182-186 (1999).
Smith, N., et al., “Total Silencing by Intron-Spliced Hairpin RNAs,” Nature, vol. 407, pp. 319-320 (2000).
Waterhouse, P., et al., “Virus Resistance and Gene Silencing in Plants can be Induced by Simultaneous Expression of Sense and Antisense RNA,” Proc. Natl. Acad. Sci. USA, vol. 95, pp. 13959-13964 (1998).
Ayash-Rashkovsky, M., et al., “Generation of Th1 Immune Responses to Inactivated, gp120-Depleted HIV-1 in Mice with a Dominant Th2 Biased Immune Profile via Imunostimulatory Oligonucleotides-Relevance to AIDS Vaccines in Developing Countries,” Vaccine vol. 20, pp. 2684-2692 (2002).
Jacque, J., et al., “Modulation of HIV-1 Replication by RNA Interference,” Nature, vol. 418, pp. 435-438 (2002).
Merkle, I., et al., “Biological Significance of a Human Enterovirus B-Specific RNA Element in the 3′ Nontranslated Region,” Journal of Virology, vol. 76, No. 19, pp. 9900-9909 (2002).
Schramke, V., et al., “Hairpin RNAs and Retrotransposon LTRs Effect RNAi and Chromatin-Based Gene Silencing,” Science, vol. 301, pp. 1069-1074 (2003).
Ryo, A., et al., “Identification and Characterization of Differentially Expressed mRNAs in HIV Type 1-Infected Human T Cells,” Aids Research and Human Retroviruses, vol. 16, No. 10, pp. 995-1005 (2000).
Ambros, V., “MicroRNAs: Tiny Regulators with Great Potential,” Cell, vol. 107, pp. 823-826 (2001).
Ambros, V., “MicroRNA Pathways in Flies and Worms: Growth, Death, Fat, Stress, and Timing,” Cell, vol. 113, pp. 673-676 (2003).
Reinhart, B., et al., “The 21-Nucleotidelet-7RNA Regulates Developmental Timing inCaenorhabditis elegans,” Nature, vol. 403, pp. 901-906 (2000).
Lagos-Quintana, M., et al., “Identification of Novel Genes Coding for Small Expressed RNAs,” Science, vol. 294, pp. 853-858 (2001).
Lee, N., et al., “Expression of Small Interfering RNAs Targeted Against HIV-1revTranscripts in Human Cells,” Nature Biotechnology, vol. 19, pp. 500-505 (2002).
Morel, J., et al., “Fertile Hypomorphic ARGONAUTE (ago1) Mutants Impaired in Post-Transcriptional Gene Silencing and Virus Resistance,” The Plant Cell, vol. 14, pp. 629-639 (2002).
Zhang, M., “Large-Scale Gene Expression Data Analysis: A New Challenge to Computational Biologists,” Genome Research, vol. 9, pp. 681-688 (1999).
Fire, A. et al.; Nature 1998;391:806-811; Macmillan Publishers Ltd, London, United Kingdom.
Brusca John S.
DeJong Eric S.
Polsinelli Shalton Welte Suelthaus PC
Rosetta Genomics Ltd
Scott, Jr. Teddy C.
LandOfFree
Bioinformatically detectable group of novel HIV regulatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioinformatically detectable group of novel HIV regulatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioinformatically detectable group of novel HIV regulatory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3724416